Symposia
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 1.0
- Options: Also available on-demand
Moderator: Michael W. Rich, MD, AGSF
Heart failure affects more than 10% of adults 75 years of age or older and is a leading cause of hospitalization, impaired quality of life, and mortality. This session will review recent advances in the field of heart failure as they apply to older adults, including pharmacotherapy, implanted devices, and exercise interventions. The session concludes with a discussion of the role of palliative care in the management of older patients with heart failure. Learning objectives: (1) describe the benefits and risks of SGLT2-inhibitors and GLP-1 receptor agonists in management of older adults with heart failure; (2) define the indications for and outcomes associated with cardiac resynchronization therapy and implantable defibrillators in older patients with heart failure; (3) describe the role of exercise and cardiac rehabilitation in the treatment of heart failure in older adults; (4) discuss the utility of palliative care and its place in the trajectory of care of older adults with heart failure.
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Andrew Zullo, PharmD |
Glucagon-like Peptide-1 Receptor Agonists Parag Goyal, MD |
Device Therapy in Older Adults with Heart Failure Dan Matlock, MD, AGSF |
Exercise and Cardiac Rehabilitation Daniel Forman, MD |
Palliative Care Sarah Goodlin, MD |
Panel Discussion and Q & A |